Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1831-1840 of 10643

Edit search filters
  1. A Phase 2, Multicenter, Study of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib in Subjects Who Have Previously Untreated Metastatic, EGFR-mutated Non-small Cell Lung Cancer (NSCLC) and BDX004 Positive Label

    Rochester, MN

  2. Patients With Patent Foramen Ovale and Endocardial Device Leads on Apixaban for Prevention of Paradoxical Emboli

    Rochester, MN

  3. Omega-3 Fatty Acids and Insulin Sensitivity

    Rochester, MN

  4. A Study of Tamoxifen Citrate for Treating Patients with Metastatic or Recurrent Breast Cancer

    Rochester, MN

  5. The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study

    Rochester, MN

  6. A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML)

    Jacksonville, FL

  7. Anti-VEGF vs. Prompt Vitrectomy for VH From PDR

    Rochester, MN

  8. A Study Comparing Temozolomide and Selumetinib for Treating Patients with Metastatic Melanoma of the Eye

    Rochester, MN

  9. Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2)

    Rochester, MN

  10. Stroke Mitigation in A-fib Reasoning Tool for Shared Decision Making

    Rochester, MN

.

Mayo Clinic Footer